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SUMMARY
We identified a 5-year outbreak of a methicillin-susceptible Staphylococcus aureus (MSSA)
strain, affecting 202 babies on a neonatal unit, by routine weekly phage typing all S. aureus
isolates. Multiple staged control measures including strict emphasis on hand hygiene,
environmental and staff surveillance sampling, and application of topical hexachlorophane
powder failed to end the outbreak. S. aureus PT 53,85 (SA5385) was found on opened packs
of Stomahesive2, used as a neonatal skin protectant. Only following the implementation of
aseptic handling of Stomahesive, and the use of topical mupirocin for staff nasal carriers of
SA5385, and for babies colonized or infected with S. aureus, did the isolation rate of SA5385
decline. DNA fingerprinting indicated that & 95% of SA5385 isolates were clonal. In itro
death rates of SA5385 on Stomahesive with human serum were significantly lower than on
Stomahesive alone (Pfl 0–04), and on cotton sheet with serum (Pfl 0–04), highlighting the
potential of this material as a survival niche. Phage typing remains a valuable, inexpensive and
simple method for monitoring nosocomial MSSA infection.
INTRODUCTION
Neonatal units provide ideal environments for
Staphylococcus aureus to persist as a nosocomial
pathogen. Most of the infants are of low birth weight,
debilitated and subjected to many invasive pro-
cedures, including the insertion of intravascular
catheters. Babies on neonatal units also develop
commensal flora which differ from those not managed
in intensive care, possibly influencing their colon-
ization by potentially pathogenic bacteria [1, 2]. S.
aureus has long been recognized as a major hospital-
acquired pathogen of neonates [3–5]. The umbilicus is
a prime site of colonization, and umbilical colon-
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ization and neonatal infection are closely related
[3–5]. Hand-borne spread is the predominant means
of staphylococcal transmission in neonatal units [6, 7].
In many outbreaks of methicillin-resistant and
methicillin-susceptible S. aureus (MRSA, MSSA),
employment of extra staff has brought about a
reduction in rates of infection [8–10]. In particular, the
employment of an infection control nurse often
improves the situation by drawing attention to and
implementing infection control measures [10]. S.
aureus survival within the hospital environment is well
documented [11–13], and some epidemic strains can
remain viable for longer on cotton lint than other
strains [14]. The mechanisms of enhanced survival are
poorly understood, but resistance to desiccation [13,
15], adherence [16], and the ability to survive on
human skin [15–17] have been implicated.
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Recently, much emphasis has been placed on
outbreaks caused by MRSA [18–21]. The spread of
MSSA has received less attention, largely because
these bacteria do not have readily identifiable anti-
biotic resistance markers, and many laboratories have
abandoned routine monitoring methods such as phage
type. We have continued to monitor and phage type
MSSA isolates, and highlight the value of such
surveillance. Routine phage typing enabled us first to
identify and then monitor the control of a 5-year
outbreak of S. aureus PT 53,85 (SA5385) in our
regional neonatal unit (subsequently confirmed by
DNA fingerprinting). Secondly, we emphasize the
epidemic potential of this MSSA strain and the
extensive measures required for its control. Thirdly,
we report the potential environmental niche provided
by Stomahesive2 (Squibb, UK), which is used as a
neonatal skin protectant. In itro staphylococcal
desiccation experiments confirmed the survival of
bacteria on Stomahesive, and successful control of the
outbreak was only achieved once aseptic handling
procedures for this material were adopted.
METHODS
Overview of the outbreak
Retrospective analysis of PT results (performed
weekly since 1980s) showed the outbreak of SA5385
began on the neonatal unit in September 1992, when
it was isolated from eye swabs taken from twin baby
girls with sticky eyes on the special care baby unit. The
outbreak was centred on the neonatal unit (145 new
isolates), but 92 SA5385 isolates were also recovered
from babies on two post-natal and paediatric intensive
care wards (usually after transfer from the neonatal
unit), and rarely from elsewhere (total% 3 isolates per
annum). Data presented pertain primarily to the
neonatal unit, which has about 900 admissions per
year (including 175 neonates weighing ! 1500 g
and}or ! 31 weeks gestation, 400 ventilated babies
and 300 surgical cases) and consists of adjoining
intensive care (10 cots, including 2 in a side room),
special care (20 cots in 3 cuticles and 1 side room) and
surgical (10 cots units, including 2 side rooms) units.
Figure 1 depicts the outbreak (but excludes multiple
patient isolates and those obtained from screening
specimens) and demonstrates peaks of new isolates of
SA5385 in 1995 and mid-1996. It was often unclear
whether isolation of SA5385 represented colonization
or infection. However, 28% of SA5385 isolates were
recovered from normally sterile sites (blood, CSF,
intravascular catheter tips, joint fluids, pleural aspir-
ates), particularly in 1994–5 (60% of invasive iso-
lates) ; the remainder were isolated from non-sterile
sites (e.g. wound, skin, eye and nasopharyngeal swabs,
urine and sputum) indicating colonization (with or
without infection). Infections caused by SA5385
ranged from conjunctivitis to septicaemia and osteo-
myelitis ; in two cases the strain was isolated from
peritoneal swabs from infants with necrotizing en-
terocolitis. The two most common clinical conditions
were conjunctivitis and respiratory compromise (ap-
noea, decreased oxygen saturation, increased tracheal
secretions, and, occasionally, consolidation on chest
X-ray). Seven sporadic cases of MRSA infection}
colonization (including EMRSA 15}16) were seen on
the neonatal unit during the outbreak period. Control
measures resulted in a marked reduction in new
SA5385 isolates in the latter half of 1996. Data were
analysed using Microsoft Excel 5.0 software.
In vitro studies
Bacterial isolates
Staphylococci were isolated from sterile and non-
sterile sites from babies on neonatal wards (using 5%
blood agar and CLED agar; Unipath, Basingstoke,
UK), and identified as S. aureus using Staphyslide
(BioMerieux, Basingstoke, UK) and DNAse testing.
Phage typing [22] was carried out using ‹100 routine
test solution of 23 international phages [23] on all S.
aureus isolates each week. Environmental testing was
carried out using blood agar settle plates, and saline
moistened, cotton wool swabs to sample 10‹10 cm
areas followed by inoculation onto blood agar. All
SA5385 isolates were stored at fi70 °C following
phage typing. Forty non-consecutive, random, stored
isolates were selected for pulse field gel electrophoresis
of chromosomal DNA, plasmid profiling an anti-
microbial susceptibility testing. For desiccation
studies, 5 randomly selected SA5385 strains, and 15
non-PT 53,85 S. aureus isolates (5 each from healthy
human volunteers, neonates and patients on other
hospital wards) were used.
Pulsed field gel electrophoresis (PFGE)
Agarose blocks were prepared using modified manu-
facturer’s instructions (BioRad, Hemel Hempstead,
UK). Briefly, strains were incubated overnight in
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Fig. 1. Frequency histogram to show the outbreak of S. aureus PT 53,85 on the neonatal unit (new patient isolates) 1992–7.
The dotted line (- -D - -) shows the numbers of other S. aureus isolates. The main intervention points, depicted by the letters,
were as follows: A, staff and environmental screening, mupirocin for carriers ; B, repeat nasal mupirocin for staff carriers plus
topical Aquasept ; C, routine topical hexachlorophane to umbilicus of neonatal unit babies post-bathing; D, measures in C
extended to babies on post-natal wards; E, treatment of all staff with nasal mupirocin and topical Aquasept, plus thorough
environmental cleaning; F, nasal mupirocin for patients carriers ; G, repeat F plus cohorting of carriers ; H, extensive staff
and environmental screening; I, extensive surveillance exercise of neonatal unit procedures ; J, Stomahesive implicated in
outbreak, aseptic handling protocol introduced; K, empirical nasal mupirocin for babies from whom S. aureus isolated. See
text for full details.
tryptone yeast extract broth (Oxoid) with 10%
glycine. Following centrifugation of 1 ml aliquots at
12000 g for 10 min at 4 °C, the deposit was washed in
1 ml of buffer (10 mm Tris, 50 mm EDTA, 1 m NaCl)
and then suspended in 0–5 ml buffer. The suspension
was heated at 50 °C and then an equal volume of 1%
low melting temperature agarose (Flowgen, Lichfield,
UK) was added and poured into moulds. For each
strain tested, two agarose blocks containing DNA
were incubated in buffer containing 1 mg}ml lysozyme
(Sigma, Poole, UK) and 200 ll}ml lysostaphin
(Sigma) for 4 h at 37 °C, then washed and incubated
overnight at 50 °C in 1 mg}ml proteinase K (Sigma).
The blocks were then washed, and digested using 20
U of restriction endonuclease (SmaI ; Helena Bio-
sciences, Sunderland, UK) for 2 h. Electrophoresis
was carried out using a CHEF–DR II system (Bio-
Rad) at 14 °C with a constant voltage of 6 V cm−" and
pulse times of 45–90 sec for 8 h, 5–25 sec for 12 h.
Gels were stained with 1 ll ml−" ethidium bromide
and photographed under u.v. light.
Plasmid analysis
Plasmid DNA was extracted from isolates using
Wizard miniprep (Promega, Southampton, UK).
Manufacturers’ instructions were modified to include
an incubation step with 2 mg}ml lysostaphin before
lysis. Plasmid DNA was analysed by electrophoresis
on 0–8% w}v agarose gels, which were then stained
and photographed as for PFGE.
Antimicrobial susceptibility testing
Determination of the MICs of 8 antibiotics, 3
antiseptics and 2 DNA binding agents for 40 strains
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was carried out by an agar dilution method (Iso-
sensitest agar, Oxoid) and multipoint inoculation of
10% d.f.u.}spot [24]. Tested compounds, obtained as
pharmaceutical grade powders}solutions or from
Sigma (breakpoint concentrations, mg}l), were acri-
flavine (32), amikacin (8), benzalkonium chloride (8),
chloramphenicol (32), chlorhexidine (4), erythromycin
(8), ethidium bromide (32), flucloxocallin (4), genta-
micin (4), netilmicin (4), penicillin (0––25), triclosan (4),
and trimethoprim (8) [24–26]. The control was S.
aureus NCTC 6571.
Resistance to desiccation
It was hypothesized that contaminated Stomahesive2
was a focus for SA5385 in the Neonatal Unit. To test
the hypothesis, we compared in itro survival rates of
20 S. aureus strains, including 5 SA5385, on
Stomahesive2 using a modified desiccation method
[15]. Overnight cultures of each strain grown in 10 ml
Brain Heart Infusion broth (Oxoid) were centrifuged,
washed, and re-suspended in 4 ml phosphate buffered
saline (PBS). Each suspension was divided into two 2
ml aliquots, and 1 ml of pooled human serum was
added to one of these. Each sample volume was then
made up to 5 ml with PBS. Aliquots (20 ll) from each
of the two samples per strain were placed on five 30
mm squares of sterile cotton sheeting, and five 10 mm
squares of Stomahesive2. Cotton squares were placed
in individual sterile 10 cm diameter Petri dishes, and
Stomahesive2 squares were stored five to a dish.
Covered Petri dishes were stored in darkness at
ambient temperatures (22 °C) and humidity. Surviving
bacteria were quantified on days 1, 7, 14, 21 and 71, by
determining viable counts on squares following broth
immersion and vortexing for 30 sec. Viable bacteria
were enumerated by tenfold dilutions of broth from
the vortexed squares, plated on blood agar by the
spread technique. The death rate per day (K ) was
calculated as Kfl 2–3‹1}t(B
!
fiB
t
), where t is the
drying time in days, B
!
fl log
"!
count at time 0, B
t
fl
log
"!
count at time t [13]. The significance of
differences in K values was determined by Student’s t
test.
RESULTS
Infection control procedures
An outbreak meeting was first held in February 1994
following a peak of SA5385 isolates 2 months
previously. Nasal swabs from 170 health carers yielded
SA5385 from 4 nurses and 1 doctor who were given
nasal mupirocin for 1 week. All were negative on
repeat swabbing. Extensive environmental sampling
was performed but no SA5385 positive sites were
identified. Hand hygiene awareness on the neonatal
unit was increased (teaching, demonstrations and
hand impression plate result feedback). No staff
attending the Caesarian section delivery of a positive
baby were SA5385 nasal carriers (April 1994). New
SA5385 isolates reduced after the first infection
control measures (Fig. 1,A), but increased steadily
over the next 5 months. Infection control measures
were re-iterated, followed by another decline in
SA5385 isolates.
In June}July 1994, 45 staff nasal swabs (26%) grew
S. aureus including 6 (4%) SA5385 (Fig. 1, B).
Carriers were treated and re-tested as before, but in
addition Aquasept (triclosan 2% w}v; Seaton Health-
care, Oldham, UK) was used for bathing}showering.
One staff member remained positive, but responded to
a further course of nasal mupirocin. Environmental
sampling did not yield any SA5385 isolates. From
July 1994, hand hygiene products available on the unit
were rationalized to Aquasept (triclosan 2% w}v) and
Manusept (isopropyl alcohol 70% v}v, triclosan 0–5%
w}v; Seaton Healthcare). A hand hygiene education
programme was started and repeated every 6 months
to maintain staff compliance. Babies admitted from
other units were screened for SA5385, although none
proved positive. A liaison nurse was identified in order
to improve communication between ward staff and
the ICT.
From September 1994, routine application of
hexachlorophane 0–33% powder (Ster-Zac, Hough
Hoseason, Manchester, UK) to the cord and umbilical
area after bathing was introduced for all babies on the
neonatal unit (Fig. 1,C), and this had a profound
effect (only two new SA5385 isolates over the next 3
months). This policy was extended to the post-natal
wards in June 1995 (Fig. 1,D), at which time extensive
environmental sampling was undertaken. SA5385 was
recovered from three settle plates in different rooms, a
cot, a baby warmer and a filing drawer. The monthly
incidence of SA5385 isolates was now at the highest
level recorded. The ICT considered either closure of
the neonatal unit, or extensive reinforcement of
infection control measures. The unit is a regional
referral centre and thus the effects of closure would
potentially be dramatic. The second option was
therefore adopted. Staff rotation in the unit was
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Table 1. Results of hand impression plate testing (July 1995)
Post-natal
ward
Post-natal
and
transitional
care ward
Neonatal
unit
Number of staff tested 22 30 49
Number positive for S. aureus 4 7 9
Number of positive for S. aureus PT 53,85 0 3 8
Number positive before handwashing 1 3 6
Number positive before and
after handwashing
3 4 3
1 2 3 4 5 6 7 8
Fig. 2. Chromosomal DNA fingerprints (PFGE profiles
following Sma I digestion) of S. aureus PT 53,85 clinical
isolates (lanes 2–3, 5–8) and a non-typable S. aureus clinical
isolate (lane 4). All isolates were recovered from sterile sites
of babies on the neonatal unit. Lane 1 contains k DNA
ladder.
minimized, and all staff were treated with nasal
mupirocin for 5 days, and Aquasept used daily for 1
week for bathing, showering and hair washing.
Thorough environmental cleaning of the unit was
carried out during and after staff treatment (Fig. 1, E).
Hand impression plate cultures from neonatal unit
and post-natal ward staff, indicates the presence of
SA5385 on washed hands (Table 1; the outbreak
strain was recovered from the hands of 8.49 neonatal
unit staff, and in 3 of these was not removed post-
washing), and therefore hand washing protocols for
were re-emphasized and included a minimum wash
for 2 min at the start of work. All infants with SA5385
nasal colonization were treated with mupirocin (Fig.
1, F). Hexachlorophane powder was used routinely on
all babies at every nappy change (umbilicus, groin and
axillae) on neonatal and post-natal wards. Laundered
clothing was sampled for SA5385 but none was
positive.
In September 1995 (Fig. 1,G) all babies on neonatal
and post-natal wards had nose, perineal, umbilical,
and skin lesion swabs taken. Eight babies colonised by
SA5385 were cohort nursed in view of limited side
room facilities. Babies were not transferred from the
unit until colonization by SA5385 had been eradi-
cated. Following reports of non-compliance, the hand
hygiene protocol was reiterated (Fig. 1,H). Staff hand
impression plates and nasal and skin lesion swabs
grew 9 S. aureus isolates, but no SA5385. None of 95
environmental samples was S. aureus positive. New
isolates were now at the lowest level since the outbreak
began, but then rose rapidly in April 1996, prompting
an extensive review of neonatal unit procedures by the
ICT (Fig. 1, I).
In June 1996 SA5385 was isolated from a used piece
of Stomahesive2 (Squibb), and then from two pieces
of pre-cut (but unused) material and the used scissors.
Stomahesive2 is supplied as a sterile product in
10‹10 cm sheets, and staff had been cutting pieces as
required to fit on neonates’ faces, to protect against
shearing forces occurring when conventional adhesive
tape is removed. Aseptic precautions had not been
observed routinely, and after sectioning remaining
Stomahesive2 was stored loosely in its original
packaging in a drawer, or in an emergency tray on the
open ward. A protocol was implemented for the
aseptic handling of Stomahesive2 (using gloves and
sterile scissors) and storage in capped, sterile con-
tainers (Fig. 1, J). As there was a delay in obtaining
phage typing results (performed weekly), nasal
mupirocin was henceforth given empirically to babies
whose clinical specimens yielded S. aureus (Fig. 1,K).
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Table 2. Comparison of in vitro death rates ( alues) of 20 S. aureus strains on Stomahesie (S ) and cotton
sheet (C ) in the presence (›hs) and absence (fihs) of human serum
C›hs Cfihs S›hs Sfihs C›hs S›hs Cfihs Sfihs
Mean (s.d.) K value 0–22 0–19 0–13 0–22 0–22 0–13 0–19 0–22
(0–02) (0–02) (0–01) (0–01) (0–02) (0–01) (0–02) (0–01)
P value* 0–65 0–04 0–04 0–68
* Two-tailed t-test.
A marked reduction in new SA5385 isolates followed
in the latter half of 1996. SA5385 was not isolated in
the first 9 months of 1997 but was then cultured from
five neonates. Four babies in cots adjacent to the new
cases were nasal carriers and treated with mupirocin.
Infection control protocols for handling of
Stomahesive2, use of alcohol hand rub, Aquasept
bathing, and use of shared items were re-emphasized.
There were no further SA5385 isolates up until the
end of March 1998. There was a 68% decrease in the
incidence of SA5385 during the 12 months after this
change in protocol (15 isolates) compared with the 12
months before (47 isolates). The incidence of non-PT
53,85 S. aureus isolates was approximately stable
during the outbreak (Fig. 1).
Staffing levels on the neonatal unit
Patient care hours (PCH) are the theoretical number
of nursing hours required to accommodate the
workload [10, 27, 28]. Nursing care hours (NCH) are
the actual number of nursing hours worked. The
greatest differences between PCH and NCH occurred
in October 1993, May 1994, and March 1995. In
respective months following these peaks, numbers of
SA5385 isolates increased on the neonatal unit. In
months when the PCH–NCH value was small (August
1994, September 1995), reduced numbers of new PT
53,85 isolates followed. However, linear regression
analysis and Pearson’s correlation coefficient indi-
cated a non-significant relationship between the
PCH–NCH values (for the current or preceding
month) and the numbers of new SA5385 (P& 0–79).
PFGE, plasmid analysis, antibiotic resistance profiles
PFGE profiles of 38}40 (95%) SA5385 isolates were
indistinguishable (Fig. 2), with the remaining two
strains closely related (three band difference) [29].
There were three plasmid profiles, differing by one or
two bands. Isolates had very similar antimicrobial
resistance profiles and 95% (38}40, with indis-
tinguishable PFGE profile) were resistant to % 4
compounds. Only resistance to penicillin (36 strains),
ethidium bromide (34), and acriflavine (34) was
common. Three strains (with the common PFGE
profile) were resistant to triclosan; these were isolated
before and after institution of triclosan hand washing.
None of the tested isolates was resistant to mupirocin.
Resistance to S. aureus to desiccation
All four groups of strains tested had similar trends in
survival rates. There were large decreases in viable
counts of most strains by day 7; the bacterial count
declined more slowly up to days 21–71. There was no
significant difference in bacterial survival rates be-
tween any of the S. aureus groups (t-test, P" 0–05).
There was also no significance between survival rates
on the cotton sheet with and without serum, or
between the cotton sheet without serum and the
Stomahesive2 without serum. However, survival rates
on Stomahesive2 with serum were significantly higher
than on Stomahesive2 alone (Pfl 0–04), and on cotton
sheet with serum (Pfl 0–04) (Table 2).
DISCUSSION
The 5-year outbreak of SA5385 was centred on
neonatal and postnatal wards, and only rare, sporadic
isolates from patents elsewhere had similar phage
types to the endemic strain. For example, a 2-year-old
child with endotracheal tube secretions colonized by
SA5385 was on the adjacent paediatric intensive care
unit for 10 months and yet spread to other unit
children was not seen. We cannot be certain of the
true number of infected as opposed to colonized
babies, but 61 isolates (from different babies) were
recovered from specimens obtained from sterile sites.
Phage typing all clinical S. aureus isolates enabled us
to identify and then monitor the outbreak strain.
DNA fingerprinting of 40 randomly selected SA5385
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isolates confirmed that the outbreak was due to a
distinct clone. While genotypic methods have become
more common, phage typing remains a simple,
inexpensive method for fingerprinting S. aureus, and
is well suited to the examination of large numbers of
strains, unlike the former techniques. Alert organism-
based surveillance may have detected this outbreak,
but it was not until 2 years after the outbreak began
that the total number of S. aureus isolates on the unit
increased markedly (Fig. 1).
There is currently much debate about control
measures for MRSA [18–21] but we are concerned
that there may be unrecognized spread of MSSA. We
can find no other reports of SA5385 outbreaks, but
this may reflect the relative rarity of routine S. aureus
phage typing. Whilst some (epidemic) MRSA clearly
have a propensity to spread, there are likewise many
examples of MSSA with similar survival advantages
[7–11]. Interestingly, during the SA5385 outbreak,
seven sporadic MRSA isolates (including EMRSA
15}16) were identified on the neonatal unit. These
were successfully contained using measures which
were unsuccessful in preventing the spread of SA5385.
Also, the incidence of S. aureus isolates other than PT
53,85 remained approximately stable during the
outbreak period (Fig. 1), so emphasising the epidemic
potential of this particular MSSA strain.
Outbreak control measures were hindered by the
long stay of some colonized babies, limited isolation
facilities, and movement of staff and babies within the
unit. Marked reductions in new SA5385 isolates
occurred (Fig. 1, interventions F and G) after limiting
intra-unit transfer and introduction of cohorting or
barrier nursing of infected}colonised babies. Transfer
within the unit may facilitate efficient use of specialist
cots and nursing care, but excessive movement can be
counter-productive, because of the impact on in-
fection control measures [30, 31]. We were unable to
confirm staff shortages as a significant factor in this
outbreak. Staphylococcal outbreaks have been linked
to staff shortages and indeed successfully controlled
by remedying this issue [8–10]. Overcrowding on
neonatal units has also been associated with cross-
infection [9]. However, the fact that we were eventually
able to control the outbreak, without reducing
numbers of babies on the unit, implies this issue was
not a major factor. SA5385 was particularly refractory
to the extensive infection control measures which were
implemented. We suspected a survival niche for the
strain but were unable to confirm sites such as
monitors or ventilators [11, 32]. Antimicrobial re-
sistance was not a factor in the persistence of SA5385,
as determined by review of pharmacy data for the four
most commonly prescribed antibiotics on the neonatal
unit, ampicillin, gentamicin, aztreonam and vanco-
mycin (data not shown). Antibiotic policy and use
remained constant during the outbreak. Hexa-
chlorophane powder as part of an umbilical care
regimen is effective [7, 33], and was initially so in this
outbreak. However, maximal effectiveness is only
likely to be achieved when used with other infection
control measures. Hand washing was the most
emphasized control measure, and was transiently
effective at reducing the incidence of new SA5385
isolates, but periodic audit indicated that staff non-
compliance occurred. Haley noted that recruitment of
an ICN from neonatal unit staff was beneficial in
obtaining compliance with hand washing protocols
[10]. The outbreak prompted us to ensure that new
staff on the unit received formal infection control
teaching in their induction scheme. Staff screening for
staphylococcal carriage was limited to nose and hands
only. When staff carried of SA5385 was detected we
used a whole body surface decontamination regimen
which would be expected to markedly reduce bacterial
density at other sites. Also, given the poor yield of the
endemic strain from repeated nose}hand staff sam-
pling exercises, it is unlikely that extended screening
would have yielded many further positive individuals.
Elsewhere, the yield of clinically significant MRSA
isolates from staff specimens is often extremely low
[34, 35].
The only intervention producing a sustained re-
sponse was the combination of aseptic handling of
Stomahesive, and the empirical use of nasal mupirocin
for babies from whom S. aureus was isolated. These
protocols were started simultaneously, although nasal
mupirocin was not used for babies with S. aureus in
respiratory secretions whilst endotracheal tubes re-
mained in situ, as we considered that nasal eradication
would be unlikely. We therefore believe that the main
factor which reduced the spread of SA5385 was the
aseptic handling of Stomahesive, so removing a
hitherto unrecognized niche for staphylococci. We
tried to confirm Stomahesive as source of SA5385 by
sampling further used pieces, but these often became
detached from babies’ faces after several days. We felt
that we had to intervene on the basis of the evidence
we had, rather than conduct a controlled observation
period. Mupirocin nasal cream appeared to be
effective in eradicating nasal carriage of SA5385,
although in September 1995, anecdotal evidence came
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to light regarding non-compliance of staff in the use of
mupirocin cream and hand washing. This may explain
why the earlier success of the mupirocin eradication
programme was not repeated in 1995, when isolation
rates increased sharply. Mupirocin resistance was not
detected during the outbreak [36]. It is usual practice
to adopt staged infection control measures. It is
possible that there was a cumulative benefit from
initial control measures, implementation of aseptic
handling of Stomahesive, and empirical use of nasal
mupirocin. Hence, it is not possible to be dogmatic
about which particular measures were critical in
preventing SA5385 transmission. Back and colleagues
[37] also found that intensive microbiological sur-
veillance (IMS) and mupirocin use was needed to
control a MRSA outbreak in neonates, but mupirocin
was ineffective at eradicating MRSA colonization.
Notably, IMS alone was effective at controlling an
outbreak recurrence.
Desiccation resistance studies showed that SA5385
behaved similarly to other S. aureus strains. However,
surface type onto which bacteria were inoculated had
a marked effect on viability. Stomahesive is highly
absorbent, and the hydrated environment allowed the
survival of S. aureus for at least 71 days. Initially,
SA5385 showed increased resistance to desiccation
compared with the other strains studied, and this may
give PT 53,85 a selective advantage. As Stomahesive is
frequently coated in situ by sweat and oro-nasal
secretions, we examined the effect of serum on
bacterial desiccation. Inoculated Stomahesive plus
serum consistently had lower bacterial death rates
than other environments, suggesting that serum aids
persistence. We have not proved a causal link between
endemic spread of S. aureus and Stomahesive use, but
have shown that this material provides a survival
niche for bacteria. Of 12}19 UK neonatal units
replying to a postal questionnaire, 2 use Stomahesive,
3 other materials, and 3 Friar’s balsam as skin
protectant materials (4 are not using any measures).
Clearly, materials which favour bacterial survival
must be used with care in individuals with such
heightened susceptibility to infection [38].
In summary, we experienced a 5-year outbreak of a
MSSA strain which was detected and monitored by
routine, weekly, phage typing of all S. aureus isolates,
and subsequently confirmed by DNA fingerprinting.
Successful control of the outbreak was only achieved
after deficiencies in the handling of a skin protectant
material were identified and a new protocol instigated.
Empirical use of mupirocin was also implemented
for babies known to be colonized}infected by S.
aureus. In itro data supported clinical observations
that Stomahesive can provide a survival niche for S.
aureus. New epidemic S. aureus strains have continued
to emerge and decline for unknown reasons. De-
lineation of the factors which determine the ability of
strains to spread epidemically will be of value in
controlling the dissemination of both MSSA and
MRSA clones.
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